Stevenage, United Kingdom · Founded 2018 · Privately Held (backing)
Operator of cell therapy research and manufacturing platform designed to make bio-processing scalable and affordable for cell and gene therapy. MFX is based in Stevenage, United Kingdom and was founded in 2018. It has raised $19.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$19.3M
Last round
—
Cap table — not yet on record
MFX's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MFX with a free account
·The complete investor list: 13 names
·Watch MFX: the Monday email on marks, rounds and moves
